Literature DB >> 20670757

The glycoprotein IIb/IIIa inhibitor wars: an update.

Peter B Berger.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20670757     DOI： 10.1016/j.jacc.2010.01.064

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  1 in total

1.  Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients.

Authors:  K S Rathod; S Antoniou; P Avari; N Ding; P Wright; C Knight; A K Jain; A Mathur; E J Smith; R Weerackody; A Wragg; D A Jones
Journal:  JRSM Cardiovasc Dis       Date:  2017-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.